Fundraising FoxAclid
New York, US · Founded 2021 · Delaware corporation · 4 known investors
Find your way into Aclid
Sign up to see every warm intro you have to Aclid
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aclid team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aclid provides an automation platform for biosecurity and biosafety compliance, offering real-time screening that generates threat assessments and risk profiles for genes, libraries, pools, viral vectors, and plasmids. It also automates verification of licenses, registrations, biosafety guidelines, and legitimate use for research organizations.
Founders & leadership
Aclid was founded in 2021 by Kevin Flyangolts.
Board
Investors · 4
How we know: 2048 Ventures's portfolio page · funding news · prnewswire.com · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$4.6M disclosed across 2 rounds · 2023
▶$3.6MraisedFeb 2024 · 8 investors · Other TechnologyRule 506(b)
- Kevin FlyangoltsExecutive Officer, Director, Promoter
- Alex IskoldDirector
- Offering amount
- $3.6M
- Amount sold
- $3.6M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1MraisedFeb 2024 · 4 investors · Other TechnologyRule 506(b)
- Kevin FlyangoltsExecutive Officer, Director, Promoter
- Alex IskoldDirector
- Offering amount
- $1.3M
- Amount sold
- $1M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase I | 2023 | $74.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Aclid do?
- Aclid provides an automation platform for biosecurity and biosafety compliance, offering real-time screening that generates threat assessments and risk profiles for genes, libraries, pools, viral vectors, and plasmids. It also automates verification of licenses, registrations, biosafety guidelines, and legitimate use for research organizations.
- Who founded Aclid?
- Aclid was founded by Kevin Flyangolts in 2021.
- Who are Aclid's investors?
- Aclid's investors include 2048 Ventures, Coalition Operators, Mute Ventures, IA Ventures.
- How much funding has Aclid raised?
- Aclid has disclosed $4.6M raised across 2 rounds.
- Where is Aclid headquartered?
- Aclid is headquartered in New York, US.